20^th Global Biomarkers and Clinical Research Summit

Biomarkers in Immune-Oncology

Immune Oncology biomarkers that can be used to identify inflamed tumors that may help to predict a pre-existing antitumor immune response. To identify the Immuno Oncology biomarkers, clarify this unique interplay between the immune system and the tumor, BMS biomarker research is concentrated on 4 types of areas. They are tumor antigens, inflamed tumor markers, immune suppression markers, and host environment factors. Immuno-Oncology (I-O) biomarkers seek to characterize the relationship between the immune system, the tumor and its microenvironment, and the host. A unique interaction of these factors, as well as Immuno Oncology biomarker presence and prevalence, contributes to the balance of activation versus suppression of the antitumor immune response.

Biomarkers in immune monitoring

Mutation analysis using Biomarkers to guide therapies

Cell proliferation Biomarkers

Predictive Biomarkers to immunotherapies

Biomarkers in Companion Diagnostics

Prognostic Biomarkers

Liquid Biopsy for Immuno-Oncology

Tumor Neoantigens as Biomarker and target identification

Biomarkers for combinational immunotherapies

Evaluation of Biomarkers in clinical trials

Role of Biomarkers in Cancer Vaccines development

Tumor Microenvironment profiling

Biomarkers for precision immune-oncology

Tumor markers in cancer care